Feb 21, 2024 / 07:00PM GMT
Unidentified Participant
Hi welcome back everyone to the next session of Citi's 2024 Virtual Oncology Leadership Summit. As a reminder, if you have questions for the company, just e-mail me got a multicity.com, and I will do my best to relay to the management team.
So with that, it's my very great pleasure to welcome the senior leadership of Syndax Pharmaceuticals. I have with me the CEO, Michael Metzger; President and Head of Research and Development, Neil Gallagher; and Anjali Ganguli, the Chief Business Officer. So welcome all of you.
Thank you so much for taking the time out of a very busy time in the company over the recent filing of both of the new applications with the FDA, which we'll get into.
Questions and Answers:
Unidentified ParticipantBut Michael maybe just to start out, if you could just give us a high level on where you are, what are the lead assets? What are the key catalysts for 2024 I already alluded to two of them and then we can take it from there to dig into the details.
Michael Metzger - Syndax